3M Drug Delivery, Spirig Pharma sign agreement; Flexible Stenting Solutions gets 510(k) clearance;

> 3M Drug Delivery Systems has signed an exclusive licensing agreement with Spirig Pharma, a Swiss maker of dermatological products. Spirig will use one of 3M's immune response modifier molecules to further its development of treatment for sun damaged skin. 3M release

> Flexible Stenting Solutions, a New Jersey-based developer of stents, has received 510(k) clearance from the FDA for an improved FlexStent Biliary Self Expanding Stent Delivery System and an expansion of Biliary stent sizes. FSS release

> The World Gold Council is, not surprisingly, quite happy that gold is being used in anti-cancer clinical trials WGC release

> Drug delivery patent application of the week: Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin Patent application

> Drug delivery abstract of the week: Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases Abstract

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.